UltraSight Raises $24M to Expand Cardiac Imaging

The big picture: UltraSight raised $24 million in Series B2 financing to expand its AI-guided cardiac imaging platform across U.S. health systems and develop new workflows for intensive care and circulatory support settings.

Why it matters:

• Addressing shortages: The platform helps overcome the persistent constraint of limited access to clinicians with specialized expertise in acquiring high-quality cardiac ultrasound images.
• Expanding access: By enabling trained medical professionals who are not professional sonographers to acquire diagnostic-quality images, AI guidance can extend cardiac imaging into more care settings.
• Informing treatment: Rapid access to cardiac imaging, particularly in time-critical care settings like intensive care and circulatory support, can directly impact treatment decisions and improve patient outcomes.

How it works:

• AI-guided acquisition: UltraSight’s Echosystem combines structured training, real-time AI guidance, and analytics to assist clinical providers in performing focused echocardiography examinations.
• FDA-cleared technology: The company’s software has received FDA 510(k) clearance to help medical professionals perform cardiac ultrasound scans, ensuring regulatory compliance and clinical validity.
• Workflow integration: The platform is currently deployed at over 10 commercial sites, including intensive care, to integrate the technology into existing clinical workflows and build evidence for AI-assisted image acquisition.

The catch: While AI-guided imaging addresses workforce shortages, widespread adoption in complex healthcare systems faces hurdles including integration with existing IT infrastructure, overcoming clinician skepticism, and demonstrating long-term cost-effectiveness. The need for qualified physician oversight for interpretation and reporting also means the technology augments, rather than replaces, expert human judgment.

Key Facts

• Company: UltraSight
• Amount: $24M
• Round: Series B2
• Investors: Alive HealthTech Growth Fund (lead), Deep Insight, Star51 Capital, Connecticut Innovations, eHealth Ventures, Mayo Clinic Ventures, NYU, Iron Nation
• Founder: Davidi Vortman
• Sector: Cardiac Imaging AI